The Market Reports

Synopsis
The global market for Infection Control Products was estimated to be worth US$ 75820 million in 2024 and is forecast to a readjusted size of US$ 94860 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.
Infection control products are items designed to prevent the spread of infections in various settings, including healthcare facilities, public spaces, and households. These products are essential in maintaining hygiene and minimizing the transmission of harmful pathogens, such as bacteria, viruses, and fungi. Common infection control products include personal protective equipment (PPE) like gloves, masks, and gowns, as well as disinfectants, hand sanitizers, surface cleaners, and sterilization equipment. These products are vital in healthcare settings to prevent hospital-acquired infections (HAIs) and ensure the safety of patients, staff, and visitors. Infection control products are also used in food industries, laboratories, and other environments where hygiene is a top priority.
The infection control products market is primarily driven by the rising prevalence of infectious diseases, both in healthcare settings and in the broader population. The COVID-19 pandemic heightened global awareness of the importance of infection control, and as a result, there is a sustained demand for products like hand sanitizers, disinfectants, gloves, masks, and surface cleaning agents. In healthcare environments, the need for stringent infection control practices to prevent hospital-acquired infections (HAIs) and protect both patients and healthcare workers remains a critical driver. Additionally, government regulations and health policies mandating the use of infection control products in hospitals, clinics, and other public spaces continue to fuel market growth, as businesses and institutions prioritize hygiene and safety standards.
However, the market faces several challenges, including issues related to the quality and efficacy of infection control products. The surge in demand during health crises like pandemics can sometimes result in an influx of substandard or counterfeit products that do not meet regulatory standards, putting users at risk. Additionally, the cost of high-quality, specialized infection control products can be a barrier for smaller healthcare providers, especially in developing regions. The over-reliance on single-use products, which contributes to environmental concerns, is another challenge facing the market. As sustainability becomes an increasingly important factor, manufacturers are under pressure to develop eco-friendly alternatives to disposable infection control products.
This report aims to provide a comprehensive presentation of the global market for Infection Control Products, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infection Control Products by region & country, by Type, and by Application.
The Infection Control Products market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infection Control Products.
Market Segmentation
By Company
3M
BD
Getinge
Kimberly-Clark Worldwide
Ansell
Steris
Lac-Mac
Top Glove
Hartalega
Zhejiang Zhengde Medical Supplies Group
PIAOAN GROUP
Winner Medical
Medpro (Hefei, China) Healthcare
BELIMED
Advanced Sterilization Products
Shinva
Tuttnauer
Steelco
Segment by Type
Consumables
Sterilization Equipment
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Infection Control Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Infection Control Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Infection Control Products in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index